Gabelli reiterates ‘buy’ rating for LDR stock: 4 points

Gabelli analysts reiterated LDR stock’s “buy” rating, according to a Risers & Fallers report.

Advertisement

Here are four points:

 

1. Gabelli has given LDR stock a price target of $38.

 

2. The stock’s 50-day moving average is $24.96 and its 200-day moving average is $23.49.

 

3. LDR has a 52-week low of $16.33 and a 52-week high of $47.12.

 

4. The stock’s market capitalization is $806.81 million.

 

More articles on devices:
Lattice Biologics to launch three MAR products — 3 highlights
Bone Biologics completes $5M+ financing round: 3 things to know
RTI Surgical launches laminoplasty fixation system: 4 key notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.